2-phenyl-4'-(methylthio)acetophenone | 73242-07-6

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 英文名称: 2-phenyl-4'-(methylthio)acetophenone
• 英文别名: 1-(4-(methylthio)phenyl)-2-phenylethanone；1-(4-methylsulfanyl-phenyl)-2-phenyl-ethanone；1-(4-(methylthio)phenyl)-2-phenylethan-1-one；1-(4-methylsulfanylphenyl)-2-phenylethanone
• CAS: 73242-07-6
• 化学式: C₁₅H₁₄OS
• 分子量: 242.342
• InChiKey: XTSWQXIWFZTMJR-UHFFFAOYSA-N

物化性质

• 熔点：
  98 °C
• 沸点：
  401.3±28.0 °C(Predicted)
• 密度：
  1.15±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  42.4
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-phenyl-4'-(methylthio)acetophenone 在 溴 作用下， 以 二氯甲烷 为溶剂， 以36.3 g (91.5%)的产率得到乙酮,2-溴-1-[4-(甲硫基)苯基]-2-苯基-
  参考文献：
  名称：

  Antihypertensive 4,5-diaryl-1H-imidazole-2-methanol derivatives

  摘要：

  抗高血压药物4-苯基-5-(4-甲磺基苯基)-α，α-双(三氟甲基)-1 H-咪唑-2-甲醇衍生物在高血压治疗中具有用处。

  公开号：

  US04576958A1
• 作为产物：
  描述：

  苯甲醛 在 potassium tert-butylate 、 palladium diacetate 作用下， 以 四氢呋喃 为溶剂， 反应 2.67h， 生成 2-phenyl-4'-(methylthio)acetophenone
  参考文献：
  名称：

  钯催化室温下通过区域选择性 Heck 芳基化由苯乙烯基醚和芳基重氮盐合成 α-芳基苯乙酮

  摘要：

  描述了从苯乙烯基醚和芳基重氮盐制备 α-芳基苯乙酮。该反应在室温下在没有配体和碱的情况下由乙酸钯催化。所开发的方法在反应条件、底物范围、官能团耐受性和产率方面极具吸引力。本方法的合成应用通过从苯乙烯醚制备 α-芳基吲哚和 3-芳基异香豆素来证明。

  DOI：

  10.1039/d1ob01503f

文献信息

• Pyridazine compounds and compositions containing the same
  申请人：Kowa Co., Ltd.

  公开号：US06348468B1

  公开（公告）日：2002-02-19

  This invention relates to pyridazine derivatives represented by the formula (1): wherein R1 represents a (substituted) aryl group, R2 represents a phenyl group substituted at 4-position by a lower alkoxyl group or a lower alkylthio group, R3 represents a lower alkoxyl group, a halogenated lower alkyl group, a lower cycloalkyl group, a (subsituted) aryl group, a (substituted) aryloxy group, a (substituted) nitrogen-containing heterocyclic ring residue, a (substituted) aminocarbonyl group or a lower alkylcarbonyl group, A represents a single bond, a lower alkylene group or a lower alkenylene group, X represents O or S, and the dashed line indicates that the carbon-carbon bond between the 4-position and the 5-position is a single bond or a double bond, or salts thereof; and also to medicines containing them as effective ingredients. These compounds have excellent inhibitory activity against interleukin-1&bgr; production, and are useful as preventives and therapeutics for immune system diseases, inflammatory diseases, ischemic diseases and the like.

  这项发明涉及由式（1）表示的吡啶嗪衍生物： 其中R1代表（取代的）芳基，R2代表在4位被低烷氧基或低烷硫基取代的苯基，R3代表低烷氧基、卤代低烷基、低环烷基、（取代的）芳基、（取代的）芳氧基、（取代的）含氮杂环环残基、（取代的）氨基羰基或低烷基羰基，A代表单键、低烷基烯基或低烷烯基，X代表O或S，虚线表示4位和5位之间的碳-碳键为单键或双键，或其盐；以及含有它们作为有效成分的药物。这些化合物对白细胞介素-1β的产生具有出色的抑制活性，并可用作免疫系统疾病、炎症性疾病、缺血性疾病等的预防和治疗药物。
• Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2
  申请人：Merck Frosst Canada, Inc.

  公开号：US05521213A1

  公开（公告）日：1996-05-28

  The invention encompasses the novel compound of Formula I as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.

  该发明涵盖了公式I的新型化合物，以及一种治疗环氧合酶-2介导疾病的方法，包括向需要此类治疗的患者施用公式I化合物的非毒性治疗有效量。该发明还涵盖了某些用于治疗环氧合酶-2介导疾病的药物组合物，其中包括公式I的化合物。
• Aryl substituted 5,5 fused aromatic nitrogen compounds as
  申请人：Merck Frosst Canada, Inc.

  公开号：US05552422A1

  公开（公告）日：1996-09-03

  The invention encompasses the novel compound of Formula I as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.

  该发明涵盖了公式I的新化合物，以及一种治疗环氧合酶-2介导疾病的方法，包括向需要该治疗的患者施用公式I化合物的非毒性治疗有效量。 该发明还涵盖了用于治疗环氧合酶-2介导疾病的某些药物组合，其中包括公式I的化合物。
• Structure-Based Design and Synthesis of Antiparasitic Pyrrolopyrimidines Targeting Pteridine Reductase 1
  作者：Abedawn I. Khalaf、Judith K. Huggan、Colin J. Suckling、Colin L. Gibson、Kirsten Stewart、Federica Giordani、Michael P. Barrett、Pui Ee Wong、Keri L. Barrack、William N. Hunter

  DOI：10.1021/jm500483b

  日期：2014.8.14

  The treatment of Human African trypanosomiasis remains a major unmet health need in sub-Saharan Africa. Approaches involving new molecular targets are important; pteridine reductase 1 (PTR1), an enzyme that reduces dihydrobiopterin in Trypanosoma spp., has been identified as a candidate target, and it has been shown previously that substituted pyrrolo[2,3-d]pyrimidines are inhibitors of PTR1 from Trypanosoma

  非洲人类锥虫病的治疗仍然是撒哈拉以南非洲地区未满足的主要健康需求。涉及新分子目标的方法很重要；蝶啶还原酶 1 (PTR1) 是一种在锥虫属中减少二氢生物蝶呤的酶，已被确定为候选靶标，之前已表明取代的吡咯并 [2,3- d ] 嘧啶是布氏锥虫PTR1 的抑制剂( J. Med. Chem. 2010 , 53 , 221–229)。在本研究中，61 个新的吡咯并 [2,3- d]嘧啶已经制备，设计了 23 种与 PTR1 复合的化合物的新晶体结构，并在屏幕上评估了对 PTR1 的酶抑制活性和体外抗锥虫活性。八种化合物在两个筛选中都具有足够的活性，可以进行体内评估。因此，尽管获得了小鼠 I 期疾病模型中锥虫杀灭活性的证据，但这些化合物对小鼠的毒性太大，无法进一步开发。
• O-acyloxime photoinitiators
  申请人：Ciba Specialty Chemicals Corporation

  公开号：US06596445B1

  公开（公告）日：2003-07-22

  Oximeester compounds of the formulae I, II, III and IV wherein R1 is phenyl, C1-C20alkyl or C2-C20alkyl optionally interrupted by —O—, C2-C20alkanoyl or benzoyl, or R1 is C2-C12alkoxycarbonyl or phenoxycarbonyl; R1′ is C2-C12alkoxycarbonyl, or R1′ is phenoxycarbonyl, or R1′ is —CONR10R11 or CN; R2 is C2-C12alkanoyl, C4-C6alkenoyl, benzoyl, C2-C6alkoxycarbonyl or phenoxycarbonyl; R3, R4, R5, R6 and R7 are hydrogen, halogen, C1-C12alkyl, cyclopentyl, cyclohexyl, phenyl, benzyl, benzoyl, C2-C12alkanoyl, C2-C12alkoxycarbonyl, phenoxycarbonyl or a group OR8, SR9, SOR9, SO2R9 or NR10R11; R4′, R5′ and R6′ are hydrogen, halogen, C1-C12alkyl, cyclopentyl, cyclohexyl, phenyl, benzyl, benzoyl, C2-C12-alkanoyl, C2-C12alkoxycarbonyl, phenoxycarbonyl, or are a group OR8, SR9, SOR9, SO2R9, NR10R11; provided that at least one of R3, R4, R5, R6, R7, R′4, R′5 and R′6 is OR8, SR9 or NR10R11; R8, R9, R10 and R11 are for example hydrogen, C1-C12alkyl, phenyl; are suitable as initiators for the photopolymerization of radically polymerizable compounds.

  氧肟化合物的公式I、II、III和IV，其中R1是苯基、C1-C20烷基或C2-C20烷基，可选地由—O—、C2-C20烷酰基或苯甲酰基中断，或者R1是C2-C12烷氧羰基或苯氧羰基；R1'是C2-C12烷氧羰基，或者R1'是苯氧羰基，或者R1'是—CONR10R11或CN；R2是C2-C12烷酰基、C4-C6烯酰基、苯甲酰基、C2-C6烷氧羰基或苯氧羰基；R3、R4、R5、R6和R7是氢、卤素、C1-C12烷基、环戊基、环己基、苯基、苄基、苯甲酰基、C2-C12烷酰基、C2-C12烷氧羰基、苯氧羰基或者一个OR8、SR9、SOR9、SO2R9或NR10R11基团；R4'、R5'和R6'是氢、卤素、C1-C12烷基、环戊基、环己基、苯基、苄基、苯甲酰基、C2-C12烷酰基、C2-C12烷氧羰基、苯氧羰基，或者是一个OR8、SR9、SOR9、SO2R9、NR10R11基团；但至少其中一个R3、R4、R5、R6、R7、R'4、R'5和R'6是OR8、SR9或NR10R11；R8、R9、R10和R11例如是氢、C1-C12烷基、苯基；适用作为引发剂用于自由基聚合可聚合化合物的光聚合。